Literature DB >> 32430483

Fibronodular hepatocellular carcinoma-a new variant of liver cancer: clinical, pathological and radiological correlation.

Jonathan Tefera1,2, Margarita Revzin1, Julius Chapiro1, Lynn Jeanette Savic1,2, David Mulligan3, Ramesh Batra3, Tamar Taddei4, Dhanpat Jain5, Xuchen Zhang6.   

Abstract

AIMS: To establish and define a new, not previously reported hepatocellular carcinoma (HCC) variant, termed fibronodular HCC (FN-HCC).
METHODS: We retrospectively reviewed 290 HCC cases and identified 29 FN-HCC and 24 scirrhous HCC (SCHCC). Clinical, pathological and radiological features of FN-HCC were reviewed and compared with 30 conventional HCCs (CV-HCC) and SC-HCC.
RESULTS: FN-HCCs were more likely to arise in non-advanced fibrotic livers with lower advanced Barcelona Clinic Liver Cancer (BCLC) stage, had lower rates of progression and longer time to progression and were more likely to be surgically resected compared with CV-HCCs and SC-HCCs. Imaging analysis of FN-HCCs demonstrated higher rates of non-peripheral washout and a new distinct pattern of enhancement which is characterised by the presence of multiple rounded nodules within a lesion embedded in fibrotic-appearing parenchyma.
CONCLUSIONS: FN-HCC may represent a specific variant of HCC with distinct pathological, radiological and clinical features with potential ramifications for outcome. © Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  classification; diagnostic techniques and procedures; liver; liver neoplasms

Year:  2020        PMID: 32430483      PMCID: PMC7674234          DOI: 10.1136/jclinpath-2020-206574

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  18 in total

1.  Macrotrabecular-massive hepatocellular carcinoma: A distinctive histological subtype with clinical relevance.

Authors:  Marianne Ziol; Nicolas Poté; Giuliana Amaddeo; Alexis Laurent; Jean-Charles Nault; Frédéric Oberti; Charlotte Costentin; Sophie Michalak; Mohamed Bouattour; Claire Francoz; Georges Philippe Pageaux; Jeanne Ramos; Thomas Decaens; Alain Luciani; Boris Guiu; Valérie Vilgrain; Christophe Aubé; Jonathan Derman; Cécile Charpy; Jessica Zucman-Rossi; Nathalie Barget; Olivier Seror; Nathalie Ganne-Carrié; Valérie Paradis; Julien Calderaro
Journal:  Hepatology       Date:  2018-05-09       Impact factor: 17.425

2.  Cancer statistics, 2020.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2020-01-08       Impact factor: 508.702

3.  Guidelines Insights: Hepatobiliary Cancers, Version 2.2019.

Authors:  Al B Benson; Michael I D'Angelica; Daniel E Abbott; Thomas A Abrams; Steven R Alberts; Daniel A Anaya; Robert Anders; Chandrakanth Are; Daniel Brown; Daniel T Chang; Jordan Cloyd; Anne M Covey; William Hawkins; Renuka Iyer; Rojymon Jacob; Andreas Karachristos; R Kate Kelley; Robin Kim; Manisha Palta; James O Park; Vaibhav Sahai; Tracey Schefter; Jason K Sicklick; Gagandeep Singh; Davendra Sohal; Stacey Stein; G Gary Tian; Jean-Nicolas Vauthey; Alan P Venook; Lydia J Hammond; Susan D Darlow
Journal:  J Natl Compr Canc Netw       Date:  2019-04-01       Impact factor: 11.908

4.  Clinicopathologic characteristics and long-term prognosis of scirrhous hepatocellular carcinoma.

Authors:  Jin Hee Lee; Moon Seok Choi; Geum Yeon Gwak; Joon Hyeok Lee; Kwang Cheol Koh; Seung Woon Paik; Byung Chul Yoo; Dongil Choi; Cheol Keun Park
Journal:  Dig Dis Sci       Date:  2012-02-11       Impact factor: 3.199

5.  Scirrhous hepatocellular carcinoma: comparison with usual hepatocellular carcinoma based on CT-pathologic features and long-term results after curative resection.

Authors:  Seong Hyun Kim; Hyo K Lim; Won Jae Lee; Dongil Choi; Cheol Keun Park
Journal:  Eur J Radiol       Date:  2007-10-31       Impact factor: 3.528

6.  Hepatocellular carcinoma. A clinical and pathologic analysis of 57 hepatectomy cases.

Authors:  K Kishi; T Shikata; S Hirohashi; H Hasegawa; S Yamazaki; M Makuuchi
Journal:  Cancer       Date:  1983-02-01       Impact factor: 6.860

7.  Natural history and treatment trends in hepatocellular carcinoma subtypes: Insights from a national cancer registry.

Authors:  Peter L Jernigan; Koffi Wima; Dennis J Hanseman; Richard S Hoehn; Syed A Ahmad; Shimul A Shah; Daniel E Abbott
Journal:  J Surg Oncol       Date:  2015-11-25       Impact factor: 3.454

8.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

9.  Scirrhous hepatocellular carcinoma on gadoxetic acid-enhanced magnetic resonance imaging and diffusion-weighted imaging: emphasis on the differentiation of intrahepatic cholangiocarcinoma.

Authors:  Min Jung Park; Young Kon Kim; Hyun Jeong Park; Jiyoung Hwang; Won Jae Lee
Journal:  J Comput Assist Tomogr       Date:  2013 Nov-Dec       Impact factor: 1.826

10.  Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017.

Authors: 
Journal:  Lancet       Date:  2018-11-08       Impact factor: 79.321

View more
  3 in total

Review 1.  Hepatocellular carcinoma: making sense of morphological heterogeneity, growth patterns, and subtypes.

Authors:  Michael S Torbenson
Journal:  Hum Pathol       Date:  2020-12-30       Impact factor: 3.526

2.  Scirrhous Hepatocellular Carcinoma: Systematic Review and Pooled Data Analysis of Clinical, Radiological, and Histopathological Features.

Authors:  Anastasia Murtha-Lemekhova; Juri Fuchs; Erik Schulz; Anthe Suzan Sterkenburg; Philipp Mayer; Jan Pfeiffenberger; Katrin Hoffmann
Journal:  J Hepatocell Carcinoma       Date:  2021-10-22

Review 3.  HCC: role of pre- and post-treatment tumor biology in driving adverse outcomes and rare responses to therapy.

Authors:  Sandeep Arora; Roberta Catania; Amir Borhani; Natally Horvat; Kathryn Fowler; Carla Harmath
Journal:  Abdom Radiol (NY)       Date:  2021-06-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.